Evidence map›Paper›PMID 30354204›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2018

USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.

Pierre-Yves Jean-Charles, Jiao-Hui Wu, Lisheng Zhang, Suneet Kaur, Igor Nepliouev, Jonathan A Stiber, Leigh Brian, Rui Qi, Virginia Wertman, Sudha K Shenoy and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Cardiomyocyte-Derived USP20 Attenuates Diabetic Cardiomyopathy by Facilitating the Degradation of STING and Mitigating STING-Mediated Inflammation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Pierre-Yves Jean-CharlesFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Jiao-Hui WuFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Lisheng ZhangFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Suneet KaurFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Igor NepliouevFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Jonathan A StiberFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Leigh BrianFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Rui QiFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Virginia WertmanFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Sudha K ShenoyFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Neil J FreedmanFrom the Departments of Medicine (Cardiology) (P.-Y.J.-C., J.-H.W., L.Z., S.K., I.N., J.A.S., L.B., R.Q., V.W., S.K.S., N.J.F.), Duke University Medical Center, Durham, NC.
Duke University · US

Funding

Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20R01HL118369 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J., SHENOY, SUDHA K · 2014 to 2017
$2.1M
Role of Drebrin in Vascular Smooth Muscle RemodelingR01HL112901 · NHLBI · DUKE UNIVERSITY · PI STIBER, JONATHAN A · 2013 to 2017
$1.9M
Anti-atherogenic Mechanisms of the Dual Rho-GEF KalirinR01HL121689 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 2014 to 2017
$1.9M
Role of Drebrin in AtherosclerosisR01HL121531 · NHLBI · DUKE UNIVERSITY · PI STIBER, JONATHAN A · 2014 to 2017
$1.1M
NHLBI NIH HHS R01 HL112901NHLBI NIH HHS R01 HL118369NHLBI NIH HHS R01 HL121531NHLBI NIH HHS R01 HL121689
6 · The paper itself

Abstract

Objective- Signaling that activates NFκB (nuclear factor κB) in smooth muscle cells (SMCs) is integral to atherosclerosis and involves reversible ubiquitination that activates proteins downstream of proatherogenic receptors. Deubiquitination of these proteins is mediated by USP20 (ubiquitin-specific protease 20), among other deubiquitinases. We sought to determine whether USP20 activity in SMCs decreases atherosclerosis. Approach and Results- To address this question, we used male Ldlr

Indexed as

AnimalsAortaAortitisAtherosclerosisCells, CulturedDisease Models, AnimalEndopeptidasesFemaleHyperplasiaInterleukin-1betaMacrophagesMaleMice, Inbred C57BLMice, KnockoutMuscle, Smooth, VascularMyocytes, Smooth MuscleEndopeptidasesInterleukin-1betaNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesReceptors, LDLReceptors, Tumor Necrosis Factor, Type IRipk1 protein, mouseTnfrsf1a protein, mouseTumor Necrosis Factor-alphaUbiquitin ThiolesteraseUsp20 protein, mouseatherosclerosisinflammationmacrophagesmiceubiquitination

Identifiers

PMID30354204
PMCPMC6205742
OpenAlexW2892540433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.